ホーム / コンテンツ / オンデマンド・ウェビナー / The Promises and Pitfalls of Gene Therapy for Rare Diseases
The Promises and Pitfalls of Gene Therapy for Rare Diseases
2021 年 4 月 30 日
オンデマンド・ウェビナー

The state of gene therapy faces much uncertainty as recent regulatory and clinical setbacks have raised questions about its promise. With only two gene therapies FDA-approved for rare diseases to date, the path to developing these medicines is still a difficult one.

This presentation exploreed how the biopharma industry can overcome development challenges in the pursuit of the promise of gene therapy.

トップに戻る
Powered by Translations.com GlobalLink OneLink Software